[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global OTC Painkiller Market Research Report 2023

December 2023 | 87 pages | ID: G7B4DA57262FEN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
There are two main types of OTC pain medicines: acetaminophen (Tylenol) and nonsteroidal anti-inflammatory drugs (NSAIDs). Aspirin, naproxen (Aleve), and ibuprofen (Advil, Motrin) are examples of OTC NSAIDs.

According to QYResearch’s new survey, global OTC Painkiller market is projected to reach US$ 27850 million in 2029, increasing from US$ 21040 million in 2022, with the CAGR of 4.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole OTC Painkiller market research.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global OTC Painkiller market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company
  • Pfizer
  • GSK
  • Grunenthal
  • Bayer
  • Sanofi
  • Eli Lilly
  • AstraZeneca
  • Endo
  • Merck
  • Depomed
  • Yunnan Baiyao
  • Teva
  • J&J
  • Allergan
Segment by Type
  • Acetaminophen
  • NSAIDs
Segment by Application
  • Hospitals
  • Drugstores
  • Others
By Region
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA
The OTC Painkiller report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Global market size, regional market size. Market Opportunities and Challenges

Chapter 3: Companies’ Competition Patterns

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6 to 10: Country Level Value Analysis

Chapter 11: Companies’ Outline

Chapter 12: Market Conclusions

Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global OTC Painkiller Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
  1.2.2 Acetaminophen
  1.2.3 NSAIDs
1.3 Market by Application
  1.3.1 Global OTC Painkiller Market Growth by Application: 2018 VS 2022 VS 2029
  1.3.2 Hospitals
  1.3.3 Drugstores
  1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global OTC Painkiller Market Perspective (2018-2029)
2.2 OTC Painkiller Growth Trends by Region
  2.2.1 Global OTC Painkiller Market Size by Region: 2018 VS 2022 VS 2029
  2.2.2 OTC Painkiller Historic Market Size by Region (2018-2023)
  2.2.3 OTC Painkiller Forecasted Market Size by Region (2024-2029)
2.3 OTC Painkiller Market Dynamics
  2.3.1 OTC Painkiller Industry Trends
  2.3.2 OTC Painkiller Market Drivers
  2.3.3 OTC Painkiller Market Challenges
  2.3.4 OTC Painkiller Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top OTC Painkiller Players by Revenue
  3.1.1 Global Top OTC Painkiller Players by Revenue (2018-2023)
  3.1.2 Global OTC Painkiller Revenue Market Share by Players (2018-2023)
3.2 Global OTC Painkiller Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by OTC Painkiller Revenue
3.4 Global OTC Painkiller Market Concentration Ratio
  3.4.1 Global OTC Painkiller Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by OTC Painkiller Revenue in 2022
3.5 OTC Painkiller Key Players Head office and Area Served
3.6 Key Players OTC Painkiller Product Solution and Service
3.7 Date of Enter into OTC Painkiller Market
3.8 Mergers & Acquisitions, Expansion Plans

4 OTC PAINKILLER BREAKDOWN DATA BY TYPE

4.1 Global OTC Painkiller Historic Market Size by Type (2018-2023)
4.2 Global OTC Painkiller Forecasted Market Size by Type (2024-2029)

5 OTC PAINKILLER BREAKDOWN DATA BY APPLICATION

5.1 Global OTC Painkiller Historic Market Size by Application (2018-2023)
5.2 Global OTC Painkiller Forecasted Market Size by Application (2024-2029)

6 NORTH AMERICA

6.1 North America OTC Painkiller Market Size (2018-2029)
6.2 North America OTC Painkiller Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America OTC Painkiller Market Size by Country (2018-2023)
6.4 North America OTC Painkiller Market Size by Country (2024-2029)
6.5 United States
6.6 Canada

7 EUROPE

7.1 Europe OTC Painkiller Market Size (2018-2029)
7.2 Europe OTC Painkiller Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe OTC Painkiller Market Size by Country (2018-2023)
7.4 Europe OTC Painkiller Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries

8 ASIA-PACIFIC

8.1 Asia-Pacific OTC Painkiller Market Size (2018-2029)
8.2 Asia-Pacific OTC Painkiller Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific OTC Painkiller Market Size by Region (2018-2023)
8.4 Asia-Pacific OTC Painkiller Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia

9 LATIN AMERICA

9.1 Latin America OTC Painkiller Market Size (2018-2029)
9.2 Latin America OTC Painkiller Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America OTC Painkiller Market Size by Country (2018-2023)
9.4 Latin America OTC Painkiller Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa OTC Painkiller Market Size (2018-2029)
10.2 Middle East & Africa OTC Painkiller Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa OTC Painkiller Market Size by Country (2018-2023)
10.4 Middle East & Africa OTC Painkiller Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE

11 KEY PLAYERS PROFILES

11.1 Pfizer
  11.1.1 Pfizer Company Detail
  11.1.2 Pfizer Business Overview
  11.1.3 Pfizer OTC Painkiller Introduction
  11.1.4 Pfizer Revenue in OTC Painkiller Business (2018-2023)
  11.1.5 Pfizer Recent Development
11.2 GSK
  11.2.1 GSK Company Detail
  11.2.2 GSK Business Overview
  11.2.3 GSK OTC Painkiller Introduction
  11.2.4 GSK Revenue in OTC Painkiller Business (2018-2023)
  11.2.5 GSK Recent Development
11.3 Grunenthal
  11.3.1 Grunenthal Company Detail
  11.3.2 Grunenthal Business Overview
  11.3.3 Grunenthal OTC Painkiller Introduction
  11.3.4 Grunenthal Revenue in OTC Painkiller Business (2018-2023)
  11.3.5 Grunenthal Recent Development
11.4 Bayer
  11.4.1 Bayer Company Detail
  11.4.2 Bayer Business Overview
  11.4.3 Bayer OTC Painkiller Introduction
  11.4.4 Bayer Revenue in OTC Painkiller Business (2018-2023)
  11.4.5 Bayer Recent Development
11.5 Sanofi
  11.5.1 Sanofi Company Detail
  11.5.2 Sanofi Business Overview
  11.5.3 Sanofi OTC Painkiller Introduction
  11.5.4 Sanofi Revenue in OTC Painkiller Business (2018-2023)
  11.5.5 Sanofi Recent Development
11.6 Eli Lilly
  11.6.1 Eli Lilly Company Detail
  11.6.2 Eli Lilly Business Overview
  11.6.3 Eli Lilly OTC Painkiller Introduction
  11.6.4 Eli Lilly Revenue in OTC Painkiller Business (2018-2023)
  11.6.5 Eli Lilly Recent Development
11.7 AstraZeneca
  11.7.1 AstraZeneca Company Detail
  11.7.2 AstraZeneca Business Overview
  11.7.3 AstraZeneca OTC Painkiller Introduction
  11.7.4 AstraZeneca Revenue in OTC Painkiller Business (2018-2023)
  11.7.5 AstraZeneca Recent Development
11.8 Endo
  11.8.1 Endo Company Detail
  11.8.2 Endo Business Overview
  11.8.3 Endo OTC Painkiller Introduction
  11.8.4 Endo Revenue in OTC Painkiller Business (2018-2023)
  11.8.5 Endo Recent Development
11.9 Merck
  11.9.1 Merck Company Detail
  11.9.2 Merck Business Overview
  11.9.3 Merck OTC Painkiller Introduction
  11.9.4 Merck Revenue in OTC Painkiller Business (2018-2023)
  11.9.5 Merck Recent Development
11.10 Depomed
  11.10.1 Depomed Company Detail
  11.10.2 Depomed Business Overview
  11.10.3 Depomed OTC Painkiller Introduction
  11.10.4 Depomed Revenue in OTC Painkiller Business (2018-2023)
  11.10.5 Depomed Recent Development
11.11 Yunnan Baiyao
  11.11.1 Yunnan Baiyao Company Detail
  11.11.2 Yunnan Baiyao Business Overview
  11.11.3 Yunnan Baiyao OTC Painkiller Introduction
  11.11.4 Yunnan Baiyao Revenue in OTC Painkiller Business (2018-2023)
  11.11.5 Yunnan Baiyao Recent Development
11.12 Teva
  11.12.1 Teva Company Detail
  11.12.2 Teva Business Overview
  11.12.3 Teva OTC Painkiller Introduction
  11.12.4 Teva Revenue in OTC Painkiller Business (2018-2023)
  11.12.5 Teva Recent Development
11.13 J&J
  11.13.1 J&J Company Detail
  11.13.2 J&J Business Overview
  11.13.3 J&J OTC Painkiller Introduction
  11.13.4 J&J Revenue in OTC Painkiller Business (2018-2023)
  11.13.5 J&J Recent Development
11.14 Allergan
  11.14.1 Allergan Company Detail
  11.14.2 Allergan Business Overview
  11.14.3 Allergan OTC Painkiller Introduction
  11.14.4 Allergan Revenue in OTC Painkiller Business (2018-2023)
  11.14.5 Allergan Recent Development

12 ANALYST'S VIEWPOINTS/CONCLUSIONS


13 APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES

Table 1. Global OTC Painkiller Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Acetaminophen
Table 3. Key Players of NSAIDs
Table 4. Global OTC Painkiller Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global OTC Painkiller Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global OTC Painkiller Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global OTC Painkiller Market Share by Region (2018-2023)
Table 8. Global OTC Painkiller Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global OTC Painkiller Market Share by Region (2024-2029)
Table 10. OTC Painkiller Market Trends
Table 11. OTC Painkiller Market Drivers
Table 12. OTC Painkiller Market Challenges
Table 13. OTC Painkiller Market Restraints
Table 14. Global OTC Painkiller Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global OTC Painkiller Market Share by Players (2018-2023)
Table 16. Global Top OTC Painkiller Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Painkiller as of 2022)
Table 17. Ranking of Global Top OTC Painkiller Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by OTC Painkiller Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players OTC Painkiller Product Solution and Service
Table 21. Date of Enter into OTC Painkiller Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global OTC Painkiller Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global OTC Painkiller Revenue Market Share by Type (2018-2023)
Table 25. Global OTC Painkiller Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global OTC Painkiller Revenue Market Share by Type (2024-2029)
Table 27. Global OTC Painkiller Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global OTC Painkiller Revenue Market Share by Application (2018-2023)
Table 29. Global OTC Painkiller Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global OTC Painkiller Revenue Market Share by Application (2024-2029)
Table 31. North America OTC Painkiller Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America OTC Painkiller Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America OTC Painkiller Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe OTC Painkiller Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe OTC Painkiller Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe OTC Painkiller Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific OTC Painkiller Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific OTC Painkiller Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific OTC Painkiller Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America OTC Painkiller Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America OTC Painkiller Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America OTC Painkiller Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa OTC Painkiller Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa OTC Painkiller Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa OTC Painkiller Market Size by Country (2024-2029) & (US$ Million)
Table 46. Pfizer Company Detail
Table 47. Pfizer Business Overview
Table 48. Pfizer OTC Painkiller Product
Table 49. Pfizer Revenue in OTC Painkiller Business (2018-2023) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. GSK Company Detail
Table 52. GSK Business Overview
Table 53. GSK OTC Painkiller Product
Table 54. GSK Revenue in OTC Painkiller Business (2018-2023) & (US$ Million)
Table 55. GSK Recent Development
Table 56. Grunenthal Company Detail
Table 57. Grunenthal Business Overview
Table 58. Grunenthal OTC Painkiller Product
Table 59. Grunenthal Revenue in OTC Painkiller Business (2018-2023) & (US$ Million)
Table 60. Grunenthal Recent Development
Table 61. Bayer Company Detail
Table 62. Bayer Business Overview
Table 63. Bayer OTC Painkiller Product
Table 64. Bayer Revenue in OTC Painkiller Business (2018-2023) & (US$ Million)
Table 65. Bayer Recent Development
Table 66. Sanofi Company Detail
Table 67. Sanofi Business Overview
Table 68. Sanofi OTC Painkiller Product
Table 69. Sanofi Revenue in OTC Painkiller Business (2018-2023) & (US$ Million)
Table 70. Sanofi Recent Development
Table 71. Eli Lilly Company Detail
Table 72. Eli Lilly Business Overview
Table 73. Eli Lilly OTC Painkiller Product
Table 74. Eli Lilly Revenue in OTC Painkiller Business (2018-2023) & (US$ Million)
Table 75. Eli Lilly Recent Development
Table 76. AstraZeneca Company Detail
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca OTC Painkiller Product
Table 79. AstraZeneca Revenue in OTC Painkiller Business (2018-2023) & (US$ Million)
Table 80. AstraZeneca Recent Development
Table 81. Endo Company Detail
Table 82. Endo Business Overview
Table 83. Endo OTC Painkiller Product
Table 84. Endo Revenue in OTC Painkiller Business (2018-2023) & (US$ Million)
Table 85. Endo Recent Development
Table 86. Merck Company Detail
Table 87. Merck Business Overview
Table 88. Merck OTC Painkiller Product
Table 89. Merck Revenue in OTC Painkiller Business (2018-2023) & (US$ Million)
Table 90. Merck Recent Development
Table 91. Depomed Company Detail
Table 92. Depomed Business Overview
Table 93. Depomed OTC Painkiller Product
Table 94. Depomed Revenue in OTC Painkiller Business (2018-2023) & (US$ Million)
Table 95. Depomed Recent Development
Table 96. Yunnan Baiyao Company Detail
Table 97. Yunnan Baiyao Business Overview
Table 98. Yunnan Baiyao OTC Painkiller Product
Table 99. Yunnan Baiyao Revenue in OTC Painkiller Business (2018-2023) & (US$ Million)
Table 100. Yunnan Baiyao Recent Development
Table 101. Teva Company Detail
Table 102. Teva Business Overview
Table 103. Teva OTC Painkiller Product
Table 104. Teva Revenue in OTC Painkiller Business (2018-2023) & (US$ Million)
Table 105. Teva Recent Development
Table 106. J&J Company Detail
Table 107. J&J Business Overview
Table 108. J&J OTC Painkiller Product
Table 109. J&J Revenue in OTC Painkiller Business (2018-2023) & (US$ Million)
Table 110. J&J Recent Development
Table 111. Allergan Company Detail
Table 112. Allergan Business Overview
Table 113. Allergan OTC Painkiller Product
Table 114. Allergan Revenue in OTC Painkiller Business (2018-2023) & (US$ Million)
Table 115. Allergan Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global OTC Painkiller Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global OTC Painkiller Market Share by Type: 2022 VS 2029
Figure 3. Acetaminophen Features
Figure 4. NSAIDs Features
Figure 5. Global OTC Painkiller Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global OTC Painkiller Market Share by Application: 2022 VS 2029
Figure 7. Hospitals Case Studies
Figure 8. Drugstores Case Studies
Figure 9. Others Case Studies
Figure 10. OTC Painkiller Report Years Considered
Figure 11. Global OTC Painkiller Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global OTC Painkiller Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global OTC Painkiller Market Share by Region: 2022 VS 2029
Figure 14. Global OTC Painkiller Market Share by Players in 2022
Figure 15. Global Top OTC Painkiller Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Painkiller as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by OTC Painkiller Revenue in 2022
Figure 17. North America OTC Painkiller Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America OTC Painkiller Market Share by Country (2018-2029)
Figure 19. United States OTC Painkiller Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada OTC Painkiller Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe OTC Painkiller Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe OTC Painkiller Market Share by Country (2018-2029)
Figure 23. Germany OTC Painkiller Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France OTC Painkiller Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. OTC Painkiller Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy OTC Painkiller Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia OTC Painkiller Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries OTC Painkiller Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific OTC Painkiller Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific OTC Painkiller Market Share by Region (2018-2029)
Figure 31. China OTC Painkiller Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan OTC Painkiller Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea OTC Painkiller Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia OTC Painkiller Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India OTC Painkiller Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia OTC Painkiller Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America OTC Painkiller Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America OTC Painkiller Market Share by Country (2018-2029)
Figure 39. Mexico OTC Painkiller Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil OTC Painkiller Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa OTC Painkiller Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa OTC Painkiller Market Share by Country (2018-2029)
Figure 43. Turkey OTC Painkiller Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia OTC Painkiller Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Pfizer Revenue Growth Rate in OTC Painkiller Business (2018-2023)
Figure 46. GSK Revenue Growth Rate in OTC Painkiller Business (2018-2023)
Figure 47. Grunenthal Revenue Growth Rate in OTC Painkiller Business (2018-2023)
Figure 48. Bayer Revenue Growth Rate in OTC Painkiller Business (2018-2023)
Figure 49. Sanofi Revenue Growth Rate in OTC Painkiller Business (2018-2023)
Figure 50. Eli Lilly Revenue Growth Rate in OTC Painkiller Business (2018-2023)
Figure 51. AstraZeneca Revenue Growth Rate in OTC Painkiller Business (2018-2023)
Figure 52. Endo Revenue Growth Rate in OTC Painkiller Business (2018-2023)
Figure 53. Merck Revenue Growth Rate in OTC Painkiller Business (2018-2023)
Figure 54. Depomed Revenue Growth Rate in OTC Painkiller Business (2018-2023)
Figure 55. Yunnan Baiyao Revenue Growth Rate in OTC Painkiller Business (2018-2023)
Figure 56. Teva Revenue Growth Rate in OTC Painkiller Business (2018-2023)
Figure 57. J&J Revenue Growth Rate in OTC Painkiller Business (2018-2023)
Figure 58. Allergan Revenue Growth Rate in OTC Painkiller Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed


More Publications